ESSA Pharma: Promising Novel Therapy For Treatment Of Prostate Cancer [Seeking Alpha]
ESSA Pharma Inc. (EPIX)
Last essa pharma inc. earnings: 2/13 05:48 pm
Check Earnings Report
US:NASDAQ Investor Relations:
essapharma.com/investors
Company Research
Source: Seeking Alpha
ESSA Pharma: Promising Novel Therapy For Treatment Of Prostate Cancer Summary ESSA recently presented promising new data on its next-generation EPI-7386 N-terminal domain androgen receptor inhibitor at ESMO for the treatment of prostate cancer. Plans to file IND and begin clinical trials for next-generation EPI-7386 in or about Q1 2020. Funded until 2023. EPI-7386 more than 20X more potent than 1st generation EPI-506 with significantly improved stability and much longer 24-hr predicted half life. Pre-clinical anti-tumor effect impressive, especially in combo with ENZ. Patent protection for EPI-7386 anticipated to 2038 or later. If Phase 1 trial results are successful, ESSA will become a potential takeover target in the next 2 years. ESSA Pharma Inc. EPIX On September 27th, I had a chance to meet with ESSA's CEO Dr. David Parkinson, MD, EVP & COO Peter Virsik, and CFO David Wood. I was impressed with ESSA's story. In the article below, the slides referenced are all taken from ESSA's pr
Show less
Read more
Impact Snapshot
Event Time:
EPIX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EPIX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EPIX alerts
High impacting ESSA Pharma Inc. news events
Weekly update
A roundup of the hottest topics
EPIX
News
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIXAccesswire
- Lost Money on ESSA Pharma Inc.(EPIX)? Contact Levi & Korsinsky Regarding an Ongoing InvestigationAccesswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIXPR Newswire
- EPIX ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your ESSA Pharma Inc. investmentAccesswire
- ATTENTION ESSA Pharma Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your RightsAccesswire
EPIX
Earnings
- 5/14/24 - Miss
EPIX
Sec Filings
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- 11/14/24 - Form SC
- EPIX's page on the SEC website